SahmAdrangi is not the typical hedge fund manager. He is the creator of Kerrisdale Capital, which is a fund that is oriented toward research. Kerrisdale, as well as Sam Adrangi, covers sectors such as biotechnology and aviation. The fund has made a total of 48+ investments, and they have openly published all of investments on the company’s website. This reflects the investor’s commitment to openness, and is also a great source of ideas for individual investors.
An Accomplished Chief Investment Officer
SahmAdrangi serves as the firm’s Chief Investment Officer. This makes him involved in all aspects of running the firm, as well as managing the investment portfolio. He created the firm in 2009, and did so with under $1 Million, which grew to a value of $150 Million under management by July 2017. As Chief Investment Officer, SahmAdrangi has also made activist investments and openly publishes his research.
Focused Heavily on Short Sale Investments
Many of the investments that the firm has made have been short sales. The company has also made investments in Chinese companies, seeing China as being a huge source of potential economic growth. He has also shorted Chinese companies known for fraud, such as the China Marine Food Group. These companies have also been targeted by the SEC for enforcement of securities laws.
Focused on Developing Expertise in Biotechnology
SahmAdrangi is also focused on developing expertise in specific areas. Biotech is a huge focus for the firm, along with being involved with capital allocation for a corporation. He began his career in credit, and has also spent a great deal of time working at hedge fund where he was responsible for working with distressed debt. Developing exposure to the biotechnology industry has been a huge benefit for Adrangi’s desire to focus.
Visit More : www.hvst.com/user/sahm-adrangi